image_alt_text
5

Shaochen Chen, Ph.D.

AIMBE College of Fellows Class of 2015
For contributions to the field of nanoengineering for biomedical applications, specifically in biomaterials, 3D bioprinting, and tissue engineering

3D Printed Implant Promotes Nerve Cell Growth to Treat Spinal Cord Injury

Via UC San Diego | January 14, 2019

For the first time, researchers at University of California San Diego School of Medicine and Institute of Engineering in Medicine have used rapid 3D printing technologies to create a spinal cord, then successfully implanted that scaffolding, loaded with neural stem cells, into sites of severe spinal cord injury in rats.

The implants, described in a study published in the January 14 issue of Nature Medicine , are intended to promote nerve growth across spinal cord injuries, restoring connections and lost function. In rat models, the scaffolds supported tissue regrowth, stem cell survival and expansion of neural stem cell axons out of the scaffolding and into the host spinal cord… Continue reading.

...

Engineers 3D-print a New Lifelike Liver Tissue for Drug Screening

Via UC Davis | February 8, 2016

A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver’s sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. The work was published the week of Feb. 8 in the online early edition of Proceedings of the National Academy of Sciences.

Researchers said the advance could help pharmaceutical companies save time and money when developing new drugs.

“It typically takes about 12 years and $1.8 billion to produce one FDA-approved drug,” said Shaochen Chen, NanoEngineering professor at the UC San Diego Jacobs School of Engineering. “That’s because over 90 percent of drugs don’t pass animal tests or human clinical trials. We’ve made a tool that pharmaceutical companies could use to do pilot studies on their new drugs, and they won’t have to wait until animal or human trials to test a drug’s safety and efficacy on patients. This would let them focus on the most promising drug candidates earlier on in the process.”

Chen and Shu Chien, a professor of Medicine and Bioengineering, director of the Institute of Engineering in Medicine at UC San Diego and recipient of a National Medal of Science, are co-senior authors of the study.

...

Shaochen Chen, Ph.D. To be Inducted into Medical and Biological Engineering Elite

Via AIMBE | March 5, 2015

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Shaochen Chen, Ph.D., Professor, Department of NanoEngineering, University of California, San Diego, to its College of Fellows. Dr. Chen was nominated, reviewed, and elected by peers and members of the College of Fellows For contributions to the field of nanoengineering for biomedical applications, specifically in biomaterials, 3D bioprinting, and tissue engineering.

...